Feature Channels
Stem Cells
Filters:
ScienceChannels:Stem Cells, Stem Cells
Keywords: |
EMBARGOEDA reporter's PressPass is required to access this story until the embargo expires on 11/23/2009 5:00 AM EST |
11/23/2009 5:00 AM EST
Released to reporters: 11/20/2009 9:30 AM EST
|
MedicineChannels:Cancer, Stem Cells
Keywords: |
Cancer-Fighting Drugs Delivered Right to the TumorAn encapsulation breakthrough may enable doctors to deliver anti-cancer drugs directly to tumors over extended time periods, while preventing the side effects of chemo and other cancer treatments. The system led to an 87% reduction in volume and an 83% reduction in weight of a treated glioma tumor in mice after two weeks. |
Released: 11/17/2009 3:15 PM EST
American Technion Society |
MedicineChannels:Genetics, Stem Cells
Keywords: |
Scientists Successfully Reprogram Blood Cells to Correct Lysosomal Storage DiseaseResearchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme – preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler’s syndrome. |
Embargo expired: 11/9/2009 3:00 PM EST
Released: 11/6/2009 12:20 PM EST
Cincinnati Children's Hospital Medical Center |
MedicineScienceChannels:Genetics, Stem Cells
Keywords: |
Scientists Reveal How Induced Pluripotent Stem Cells Differ from Embryonic Stem Cells and Tissue of DerivationThe same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from adult cells, according to new research from Johns Hopkins and Harvard. |
Released: 11/4/2009 4:00 PM EST
Johns Hopkins Medicine |
MedicineChannels:Stem Cells, Stem Cells
Keywords: |
Of Mice and Men: Stem Cells and Ethical UncertaintiesThe recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's Berman Institute of Bioethics. |
Released: 10/29/2009 2:35 PM EDT
Johns Hopkins Medicine |
MedicineChannels:Stem Cells |
USC Physician-Researchers Receive $16 Million Grant From State Stem Cell AgencyPhysician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute for Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly. |
Released: 10/28/2009 9:00 PM EDT
University of Southern California |
MedicineChannels:Stem Cells
Keywords: |
Cedars-Sinai Researchers Awarded $5.5 Million To Develop Novel Stem Cell Treatments for Heart Attack PatientsA team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients. |
Released: 10/28/2009 8:45 PM EDT
Cedars-Sinai Medical Center |
MedicineChannels:Stem Cells
Keywords: |
$20 Million Stem Cell Grant for UC San Diego Cancer ResearchResearchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells. |
Released: 10/28/2009 4:00 PM EDT
University of California, San Diego Health Sciences |
ScienceChannels:Stem Cells
Keywords: |
Stem Cell Therapy May Offer Hope for Acute Lung InjuryResearchers at the University of Illinois at Chicago College of Medicine have shown that adult stem cells from bone marrow can prevent acute lung injury in a mouse model of the disease. |
Released: 10/28/2009 3:40 PM EDT
University of Illinois at Chicago |
MedicineChannels:Stem Cells, Stem Cells
Keywords: |
Salk Institute Scientist Receives $15.6 Million CIRM Disease Team Award to Develop Novel Stem-Cell Derived Therapy for Lou Gehrig’s DiseaseThe Salk Institute has been awarded a $15.6 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) – or Lou Gehrig’s Disease. |
Released: 10/28/2009 3:15 PM EDT
Salk Institute for Biological Studies |

